Back to KROS
VANGUARD CAPITAL MANAGEMENT LLC → KROS
VANGUARD CAPITAL MANAGEMENT LLC KROS Position History
Keros Therapeutics, Inc. • Healthcare
Quarters held
4
Latest value
$9.5M
Q3 2026
Peak value
$9.5M
First seen
Q1 2026
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q1 2026 | $9.2M |
| Q1 2026 | $9.2M |
| Q2 2026 | $8.9M |
| Q3 2026 | $9.5M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $9.5M | 832.7K | — | — |
| Q2 2026 | $8.9M | 833.6K | — | — |
| Q1 2026 | $9.2M | 831.4K | — | — |
| Q1 2026 | $9.2M | 831.4K | — | — |